How to Value a Pre-Revenue Startup: Berkus, Scorecard, and VC Method Explained
Jeet Chaudhary
on
When your startup exists only on a spreadsheet and a compelling pitch deck, ask What is this company worth? It feels impossible. Yet if you are seeking funding, hiring employees with equity, or preparing for a future exit, you need a defensible answer.
The startup valuation paradox is this: the companies that need a valuation most are the ones with the fewest financial metrics to support one. There's no cash flow to analyze. No revenue for the project. No comparable transactions in your industry. Yet under Internal Revenue Code Section 409A, you are legally required to establish fair market value before issuing any employee stock options and doing so incorrectly exposes your team to income tax plus a 20% excise tax penalty.
By 2026, this problem has become more acute. Venture capital markets remain competitive. Early-stage employees expect equity packages tied to defensible fair market values under IRS guidelines. Pre-revenue founders can no longer rely on informal handshake agreements.
In this guide, we will walk you through six industry-standard approaches: the Berkus Method, the Scorecard Method, Risk Factor Summation, Cost-to-Duplicate, and the VC Method. Each has distinct strengths, limitations, and appropriate use cases. We will also cover SAFE agreements, equity dilution, and the critical 409A trigger events that require valuation updates.
Understanding Pre-Revenue Startup Valuation
Pre-revenue startup valuation is an independent assessment of fair market value (FMV) for a company that has not yet generated income. Without revenue or earnings, traditional valuation methods don't apply directly.
Instead, appraisers value startups by assessing:
- Founding team strength and track record - Have they built companies before?
- Market opportunity size - Is the addressable market large enough?
- Intellectual property and prototype progress - Can they execute the vision?
- Strategic partnerships or customer commitments - Do they have early traction signals?
- Competitive positioning - Is there a defensible moat?
According to the AICPA, best practices for early-stage company valuation require appraisers to document the rationale for method selection and calibrate conclusions against comparable transactions. Without that calibration, a valuation cannot withstand IRS review or investor scrutiny.
Top Six Pre-Revenue Startup Valuation Methods
Investors and appraisers apply six distinct methods to pre-revenue startups, often combining two or three to triangulate a defensible fair market value. The right choice depends on your company's stage, the purpose of the valuation (409A compliance, investor negotiation, or acquisition due diligence), and what financial data is available.
Method 1: The Berkus Method
The Berkus Method assigns up to $500,000 to each of five startup milestones, creating a pre-money valuation ceiling near $2.5 million for the earliest-stage companies.
Developed by angel investor Dave Berkus, this method was designed for early-stage technology startups. Each milestone represents a category of risk the startup has reduced:
| Milestone | Max Value | Risk Reduced |
|---|---|---|
| Sound idea (basic value) | $500,000 | Market risk (does anyone want this?) |
| Prototype (working proof of concept) | $500,000 | Technology/execution risk |
| Quality management team | $500,000 | Leadership/execution risk |
| Strategic relationships (partnerships, LOIs) | $500,000 | Market/channel risk |
| Product rollout or initial sales | $500,000 | Revenue/scaling risk |
Product rollout or initial sales $500,000 Revenue/scaling risk 2026 Example: FinTech Startup with Strong Team: A FinTech startup founded by two JPMorgan engineers with a working MVP and a letter of intent from a regional bank:
- Sound idea: $500,000 (proven banking infrastructure need)
- Prototype: $500,000 (fully functional MVP)
- Management team: $500,000 (JPMorgan executives, multiple shipped products)
- Strategic relationships: $400,000 (LOI from one regional bank, early conversations with three others)
- Traction: $0 (in beta, no paying customers yet)
Berkus valuation: $1.9M pre-money
Important: This FinTech startup likely merits a higher valuation in real-world fundraising (institutional investors might value it at $6M–$10M based on the $40B+ payment infrastructure opportunity and team strength). This is precisely why the Berkus method is typically combined with Scorecard or VC methods to triangulate a full picture.
Strengths: Simple, transparent, easy to explain to angels. Focuses on controlling milestones.
Limitations:
- Doesn't account for market size or opportunity scale
- $500K per-milestone ceiling caps maximum at $2.5M regardless of market potential
- Can be too simplistic for Series A and institutional rounds
- Works best when combined with other methods
Method 2: The Scorecard Method
The Scorecard Method benchmarks your startup against the typical successful startup in its stage and geography, then adjusts for specific characteristics that make your company stronger or weaker.
Formula: Pre-Money Valuation = Reference Valuation × (1 + Sum of Adjustments)
Key adjustment factors:
- Strength of management team (0-30% adjustment)
- Size of addressable market opportunity (0-25% adjustment)
- Product/technology quality (0-15% adjustment)
- Strategic relationships (0-10% adjustment)
- Competitive environment (-25% to 0% adjustment)
- Marketing/sales execution capability (0-10% adjustment)
- Capital efficiency/funding needs (0-10% adjustment)
2026 Example: A healthcare AI startup in Atlanta with a reference valuation of $6M (typical seed-stage healthcare tech):
- Management team (Stanford PhD + practicing radiologist MIT): +25%
- Market opportunity ($40B+ diagnostic imaging): +20%
- Product/technology (proprietary deep learning, peer-reviewed): +12%
- Strategic relationships (two hospital network LOIs): +8%
- Competition (three well-funded competitors, but FDA path differentiated): -15%
- Marketing/sales (founder has healthcare network): +6%
- Funding efficiency (18-month runway): +5%
Total adjustments: +61% Valuation = $6M × 1.61 = $9.66M pre-money
Strengths: More nuanced than Berkus; accounts for company-specific differentiation; works across industries with slight customization.
Limitations: Requires accurate reference valuation data; adjustments are still subjective; relies on comparable company availability.
Method 3: Risk Factor Summation
Risk Factor Summation starts with an average pre-money value for comparable companies, then adjusts downward (or upward) for 12 defined risk categories:
- Management depth and experience
- Stage of product development
- Legislative/regulatory risk
- Competitive environment intensity
- Sales and marketing execution
- Funding/capital requirements
- Channel partnerships
- Technology/IP defensibility
- Market size and TAM
- Customer concentration risk
- Dependency on key personnel
- Macroeconomic environment
Each factor receives a risk rating (low, medium, high), and negative adjustments compound downward from the comparable baseline. This method is particularly useful when you have access to recent comparable rounds in your sector.
Method 4: Cost-to-Duplicate
Cost-to-Duplicate establishes a value floor based on cumulative investment made to date. If a startup has raised $1.2M in seed funding and spent it on team salaries, development, and go-to-market, the cost-to-duplicate that work establishes a minimum valuation of approximately $1.2M.
This method answers the question: "What would it cost an investor to rebuild this startup from scratch?" It provides a defensible floor-valuation that falls below cost-to-duplicate are difficult to justify, even in an early stage.
Method 5: Income Approach Using DCF
The Discounted Cash Flow (DCF) method projects future revenues and applies a discount rate to arrive at a present value. For pre-revenue startups, this requires credibly supported financial projections-meaning projections anchored to customer letters of intent, signed contracts, or market data demonstrating viability. /p>
Without credible projections, DCF carries less weight for pre-revenue companies. However, once a startup has piloted customers or early revenue, DCF becomes increasingly reliable.
Method 6: The VC Method (Venture Capital Method)
The VC Method works backward from a projected exit value, allocating risk and return expectations to determine present worth.
Formula: Pre-Money Valuation = (Projected Exit Value ÷ Desired Return Multiple) − Investment Amount
2026 Example: A SaaS startup seeking $3M for a seed round:
- Projected exit (5–7-year horizon): $180M (5x revenue on $36M ARR-typical 2026 SaaS exit)
- Desired return multiple: 20x (typical for seed-stage venture risk)
- Investment amount: $3M
Calculation: ($180M ÷ 20x) − $3M = $9M − $3M = $6M pre-money
At a $6M pre-money + $3M investment, the investor receives 33.3% equity ($3M ÷ $9M post-money). At a $180M exit, that stake is worth $60M-a 20x return.
2026 Return Expectations: According to National Venture Capital Association (NVCA) data (2024), typical seed-stage pre-money valuations average $8M-$12M for rounds with institutional lead investors. Pre-revenue companies without institutional backing typically see $1M-$4M valuations.
Strengths: Directly aligned with investor thinking; accounts for risk through return multiples; scales across funding rounds.
Limitations: Relies on speculative exit assumptions; sensitive to valuation multiple changes; less appropriate for non-venture-scale businesses or early angel rounds.
When Each Method Makes Sense
| Method | Best Use Case | Typical Round | Investor Acceptance |
|---|---|---|---|
| Berkus | Evaluating specific milestones; angel checks | Pre-seed, seed | Very high (simple, clear) |
| Scorecard | Benchmarking against peers | Seed, early Series A | High (widely recognized) |
| Risk Factor Summation | Detailed risk adjustment from comparable data | Seed, Series A | High (rigorous) |
| Cost-to-Duplicate | Establishing value floor | Any stage | High (practical floor) |
| DCF | When credible customer commitments exist | Pre-revenue to Series A | Medium (requires projections) |
| VC Method | Venture-backed institutional rounds | Series A, B, later | Very high (investor language) |
Best Practice: Triangulate all applicable methods. If Berkus yields $4M, Scorecard yields $6M, and VC yields $8M; your defensible range is $4M-$8M, with $6M as the conservative middle estimate.
SAFE Agreements, Equity Dilution, and Valuation Triggers
A Simple Agreement for Future Equity (SAFE) is a widely used pre-revenue financing instrument that grants investors the right to receive equity at a future priced round, typically at a discount (15-25%) or subject to a valuation cap.
Key point: SAFEs do not require a 409A valuation at issuance because no share price is set. However, once a SAFE converts equity at a priced round, a new 409A valuation must be completed before issuing additional stock options.
Each new funding round creates new shares, reducing existing shareholders' percentage of ownership. Founders and early employees who hold options granted before a round absorb dilution through lower ownership percentages at exit-not through a change to their original option price.
Mistake: Founders who don't update their 409A after a material funding event risk issuing options below fair market value. Under IRC Section 409A (2024), option recipients then owe income tax on the discount at vesting, plus a 20% excise tax, creating significant personal liability.
Six 409A Trigger Events Requiring Valuation Updates
Under IRS guidance, a startup must update its 409A valuation after these six specific triggering events:
1. First Option Grant
A 409A valuation must be completed before the startup issues any employee stock options. Without one, option recipients face income tax plus 20% excise tax on the grant date.
2. New Priced Round
After closing any equity financing round at a new valuation, a refreshed 409A is required before issuing additional options. Your post-money valuation from the round typically informs the new 409A.
3. Material Event
Significant business developments trigger valuation updates:
- Closing a major customer contract worth >20% of projected revenue
- Achieving regulatory approval (FDA clearance, etc.)
- Receipt of an acquisition offer
- Significant technology breakthrough or IP development
- Substantial change in market conditions
4. Annual Refresh (Even Without Material Events)
If no major funding event has occurred but option grants continue, IRC Section 409A best practices recommend updating the 409A every 12 months.
5. Pre-Transaction Valuation
Before any merger, acquisition, or asset sale, a current 409A ensures that option holders receive tax-compliant treatment in the transaction and that the company can defend the equity value used in the deal.
6. SAFE or Convertible Note Conversion
When SAFEs or convertible notes convert to priced equity, a new 409A must be completed before issuing options at the new valuation. This is critical because the conversion rate and resulting per-share price depend on the conversion terms.
Building a Defensible Valuation: Key Requirements
1. Method Triangulation
Use at least two methods (ideally three). If results diverge significantly, increase the weight of the most defensible method based on available data.
2. Professional Documentation
Present your valuation in a structured report including:
- Executive summary of methodology selected and why
- Detailed assumptions and justifications
- Comparable company analysis and data sources
- Management team credentials and track record
- Product roadmap and commercialization timeline
- Market research supporting opportunity size
3. Comparable Company Benchmarking
Use resources like PitchBook (venture term sheets and multiples), Crunchbase (funding announcements), and founder networks (direct conversations with peers) to calibrate your valuation against recent comparable rounds.
4. Professional Appraiser
For any serious funding round or equity issuance, hire an independent valuation professional with IRS safe harbor experience. Self-valuations do not qualify for safe harbor protection.
Strategic Considerations for 2026 Pre-Revenue Valuations
By 2026, venture markets are traction focused. Pre-revenue startups without pilot customers, beta users, or letters of intent face significant headwinds. Expect valuations to compress without demonstrated progress.
2026 Venture Environment: Capital flows to early-stage funds post-correction. However, investors are selective founders who need strong narratives, experienced teams, and clear AI integration. Startups are expected to achieve significant milestones within 18-24 months.
409A Safety Harbor: An independent appraisal completed before options are granted provides safe harbor protection. Missing this requirement exposes option recipients to income tax plus 20% excise tax on the grant date-a material tax liability with no cash distribution to fund it.
The Role of Virtue CPAs: Strategic Guidance for Pre-Revenue Valuations
Navigating pre-revenue valuation requires more than templates-it requires strategic financial expertise that bridges startup reality with investor and regulatory requirements.
Virtue CPAs specialize in startup valuations that withstand investors and IRS scrutiny. We help founders:
- Select and apply defensible methodology - Choose the right method(s) for your stage and investor base
- Develop comprehensive documentation - Create detailed reports with assumptions, benchmarks, and calculations
- Bridge 409A with fundraising - Ensure fair market value and investor valuations align to minimize audit risk
- Plan valuation progression - Model realistic increases across seed, Series A, Series B as you achieve milestones
- Support due diligence - Provide professional-grade documentation that accelerates investor closings
Our process: We assess your stage, review comparable funding data in your sector, model the applicable methods, triangulate to a defensible range, and deliver a professional report that gives investors and your employees confidence in your valuation.
Conclusion
For pre-revenue startup valuation is ultimately about credibility, alignment, and defensibility. You will never know the "true" value of a company that doesn't yet exist. What matters is that you've applied a systematic method that investors and regulators recognize, documented your assumptions rigorously, and built a case that holds up under scrutiny.
Use multiple methods, triangulate to a defensible range, and let your narrative (team, market, product, traction) justify where you land within that range. And if you are issuing equity or raising serious capital, invest in professional support-the cost is negligible relative to the protection it provides.
Frequently Asked Questions
Jeet Chaudhary
Jeet Chaudhary serves as the Chief Operating Officer at Virtue CPAs, where he leads the firm’s Global Control Centre and oversees end-to-end operational excellence.
